Search results
New research platform assesses brain cancer mutations during surgery
Science Daily· 6 days agoThe platform uses mass spectrometry to identify a key gene mutation in brain cancer, known as isocitrate dehydrogenase (IDH) mutations, in real time. Mass spectrometry is ...
Mother backs Epsom Derby auction to honour daughter
BBC via Yahoo News· 5 days agoFunds raised by the event will be used by the charity for research at its centres across the UK, with the aim of finding a cure for brain cancer. Emily,...
Gene therapy offers huge potential for combating disease, doctors say
United Press International via Yahoo News· 5 days agoResearchers are engineering ways to alter genes or swap flawed ones with healthy replacements,...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days agoSapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation PR Newswire TARRYTOWN, N.Y., June 1, 2024 -Data demonstrates durable responses across 3 cohorts of patients with
Epsom Derby: Mother backs event to honour daughter
BBC News· 5 days agoA mother from Surrey is marking the fifth anniversary of her daughter’s death by supporting a charity hat auction at the Epsom Derby. Debi Oliver, a...
Gene therapy offers huge potential for combating disease, doctors say
UPI· 5 days ago1 of 3 | Dr. Krystof Bankiewicz collaborates with his team in the lab at The Ohio State University...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days agoResults from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment Initial data from Phase 0/1 “trigger” (“window of
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoIN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies, presented encouraging preliminary clinical data of INB-200 at ...
